Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Nov 3;15(11):e0241742.
doi: 10.1371/journal.pone.0241742. eCollection 2020.

Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions

Arthur Eumann Mesas  1   2 , Iván Cavero-Redondo  1   3 , Celia Álvarez-Bueno  1   3 , Marcos Aparecido Sarriá Cabrera  2 , Selma Maffei de Andrade  2 , Irene Sequí-Dominguez  1 , Vicente Martínez-Vizcaíno  1   4
Affiliations
Meta-Analysis

Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions

Arthur Eumann Mesas et al. PLoS One. .

Abstract

Objective: Risk factors for in-hospital mortality in confirmed COVID-19 patients have been summarized in numerous meta-analyses, but it is still unclear whether they vary according to the age, sex and health conditions of the studied populations. This study explored these variables as potential mortality predictors.

Methods: A systematic review was conducted by searching the MEDLINE, Scopus, and Web of Science databases of studies available through July 27, 2020. The pooled risk was estimated with the odds ratio (p-OR) or effect size (p-ES) obtained through random-effects meta-analyses. Subgroup analyses and meta-regression were applied to explore differences by age, sex and health conditions. The MOOSE guidelines were strictly followed.

Results: The meta-analysis included 60 studies, with a total of 51,225 patients (12,458 [24.3%] deaths) from hospitals in 13 countries. A higher in-hospital mortality risk was found for dyspnoea (p-OR = 2.5), smoking (p-OR = 1.6) and several comorbidities (p-OR range: 1.8 to 4.7) and laboratory parameters (p-ES range: 0.3 to -2.6). Age was the main source of heterogeneity, followed by sex and health condition. The following predictors were more markedly associated with mortality in studies with patients with a mean age ≤60 years: dyspnoea (p-OR = 4.3), smoking (p-OR = 2.8), kidney disease (p-OR = 3.8), hypertension (p-OR = 3.7), malignancy (p-OR = 3.7), diabetes (p-OR = 3.2), pulmonary disease (p-OR = 3.1), decreased platelet count (p-ES = -1.7), decreased haemoglobin concentration (p-ES = -0.6), increased creatinine (p-ES = 2.4), increased interleukin-6 (p-ES = 2.4) and increased cardiac troponin I (p-ES = 0.7). On the other hand, in addition to comorbidities, the most important mortality predictors in studies with older patients were albumin (p-ES = -3.1), total bilirubin (p-ES = 0.7), AST (p-ES = 1.8), ALT (p-ES = 0.4), urea nitrogen (p-ES), C-reactive protein (p-ES = 2.7), LDH (p-ES = 2.4) and ferritin (p-ES = 1.7). Obesity was associated with increased mortality only in studies with fewer chronic or critical patients (p-OR = 1.8).

Conclusion: The prognostic effect of clinical conditions on COVID-19 mortality vary substantially according to the mean age of patients.

Prospero registration number: CRD42020176595.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist

Figures

Fig 1
Fig 1. Flow diagram of the literature search and studies selection.
See this image and copyright information in PMC

References

    1. World Health Organization W. Coronavirus disease 2019 (COVID-19). Situation Report– 72. 2020.
    1. Coalition C-CR. Global coalition to accelerate COVID-19 clinical research in resource-limited settings. The Lancet. 2020. Epub April 2, 2020 10.1016/S0140-6736(20)30798-4 - DOI - PMC - PubMed
    1. Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15:e0234765 Epub 2020/06/24. 10.1371/journal.pone.0234765 eCollection 2020. - DOI - PMC - PubMed
    1. Keeley P, Buchanan D, Carolan C, Pivodic L, Tavabie S, Noble S. Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary. BMJ Support Palliat Care. 2020. Epub 2020/05/30. 10.1136/bmjspcare-2020-002368 . - DOI - PubMed
    1. Karlsen APH, Wiberg S, Laigaard J, Pedersen C, Rokamp KZ, Mathiesen O. A systematic review of trial registry entries for randomized clinical trials investigating COVID-19 medical prevention and treatment. PLoS One. 2020;15(8):e0237903 Epub 2020/08/21. 10.1371/journal.pone.0237903 - DOI - PMC - PubMed

Publication types